Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 499 for your search:
Drug:
cisplatin
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase:
Phase IV, Phase III
Type:
Treatment
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
GPOH-NB2004
, EU-20661, NCT00410631
2.
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
ADO-MM-PAL8
, NCT00226473
3.
p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
ASSO OE-1
, EudraCT 2006-006647-31, NCT00525200
4.
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CMNa-ESO-01-2007
, NCT00642239
5.
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Phase:
Phase IV
Type:
Supportive care, Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
UMCN-AKF 07.02
, EudraCTnr 2007-003347-73, NCT00588835
6.
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-Small-Cell Lung Cancer (NSCLC)
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
97-02-12
, NCT00686322
7.
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2006-13
, NCT00911092
8.
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
UARK 2003-26
, NCT00090493
9.
Phase II/III Randomized Study of Fluorouracil, Cisplatin, and Radiotherapy Versus Gemcitabine Hydrochloride and Oxaliplatin in Patients With Unresectable, Nonmetastatic Cancer of the Biliary Tract
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FFCD-9902
, SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135
10.
Phase II/III Randomized Study of Neoadjuvant and Adjuvant Chemotherapy Comprising Epirubicin Hydrochloride, Cisplatin, and Capecitabine With or Without Bevacizumab in Patients With Previously Untreated, Resectable Gastric or Gastroesophageal Junction Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MRC-ST03
, EU-20710, ISRCTN46020948, EUDRACT-2006-000811-12, CTA-00316/0221/001, NCT00450203
11.
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
HFHS 05-03
, NCT00448240
12.
Phase II/III Randomized Study of Chemoradiotherapy Comprising Cisplatin, Capecitabine, and Radiotherapy With or Without Cetuximab in Patients With Carcinoma of the Esophagus
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WCTU-SCOPE-1
, EU-20739, EUDRACT-2006-002241-37, ISRCTN47718479, CTA-17853/0202/001-0001, NCT00509561
13.
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
12 to 80
Sponsor:
Other
Protocol IDs:
A-39/29.1.2007
, ICMR No-5/8/7/26/99-ECD-I, NCT00522405
14.
Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
Phase:
Phase III, Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
17 to 75
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
PH-CP010
, NCT00518869
15.
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
Phase:
Phase III, Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
C4697R
, CDR0000546570, NCRAR-VA-1810, OHSU-3288, NCT00477607
16.
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
IFCT-GFPC-ELCWP-0701
, NCT00651456
17.
Phase II/III Randomized Study of Radiochemotherapy Comprising the FOLFOX Regimen Versus Fluorouracil and Cisplatin (Herskovic Regimen) as First-Line Therapy in Patients With Inoperable Esophageal Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
FRE-FNCLCC- ACCORD-17/0707
, FRE-FNCLCC- ACCORD-17/0707, EU-20848, NCT00861094
18.
TAilored Post-Surgical Therapy in Early Stage NSCLC
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
IFCT-0801
, Eudract : 2008-004939-38, NCT00775385
19.
Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
GUIKEGONG-0816004-40
, NCT00778908
20.
Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
20 to 79
Sponsor:
Other
Protocol IDs:
ACE500
, NCT00843934
21.
Phase II/III Randomized Study of Adjuvant Therapy Comprising Gemcitabine Hydrochloride With Versus Without Cisplatin, Epirubicin Hydrochloride, and Fluorouracil Followed by Chemoradiotherapy With Fluorouracil or Capecitabine in Patients With Stage IB, II, or III Adenocarcinoma of the Pancreas
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
SRSI-PACT-7
, PACT-7, EU-20932, NCT00960284
22.
Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
R-09-025
, NCT00907543
23.
Bevacizumab in Extensive Small Cell Lung Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
IFCT-0802
, 2009-010187-42, NCT00930891
24.
A Randomised Phase II/III Study of Cediranib (AZD2171) or Placebo in Combination With Cisplatin/Gemcitabine for Patients With Advanced Biliary Tract Cancers
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
ABC-03 09/0193
, NCT00939848
25.
Phase II/III Randomized Study of Intravenous Paclitaxel and Carboplatin Versus Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Cisplatin Versus Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Stage IIB-III or Stage IV (With Only Pleural Effusion) Ovarian Epithelial, Primary Serous Type Peritoneal, or Fallopian Tube Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CAN-NCIC-OV21
, OV.21, UCL08/0379, GEICO-0902, NCT00993655
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
